Evangeline Elsa is a journalist at Gulf News. She focuses on themes of climate change, animal rights, and healthcare, weaving together narratives that advocate for equality and compassion towards animals and the environment. Evangeline's work has been featured in WIRED Middle East, Tech News Tube, and WIRED.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Dubai, United Arab Emirates (Local)
Not enough data
Evangeline Elsa's coverage primarily focuses on entertainment news, events, and government announcements related to Dubai and South Korea. She covers a wide range of topics including viral content, film industry updates, local activities for children and weather-related news in the UAE.
For effective outreach to Evangeline Elsa, consider providing pitches related to trending entertainment news from Dubai or South Korea. This could include exclusive interviews with celebrities or insights into popular culture phenomena such as films like "Parasite" or K-pop groups like BTS. Additionally, she may be interested in event coverage involving cultural festivals or community activities within these regions.
Given her focus on government announcements and significant events in Dubai and South Korea, relevant pitches could involve exclusive access to official statements regarding public initiatives or noteworthy developments within these locations.
This information evolves through artificial intelligence and human feedback. Improve this profile .
As ships return to the Strait of Hormuz, mines, sonar and congestion continue to reshape the Gulf beneath the surface.
9 pts As ships return to the Strait of Hormuz, mines, sonar, and congestion continue to reshape the Gulf beneath the surface.
As ships return to the Strait of Hormuz, mines, sonar, and congestion continue to reshape the Gulf beneath the surface.
The Gulf and Red Sea hold some of the world’s most climate-resilient corals. But shipping disruption, pollution and conflict put them at risk.
By: Evangeline Elsa
As GLP-1 drugs move to pills, the race is shifting from weight loss to long-term use, and how long patients stay on treatment.
